Report Description

United States interventional cardiology devices market is expected to grow at a significant rate during the forecast period. Increasing prevalence of coronary artery diseases is driving the demand for interventional cardiology devices market. Surge in adoption of unhealthy lifestyle such as consumption of junk food and sugary food items and beverages is expected to give rise to a number of health-related issues. Prevalence of sedentary lifestyle which leaves less time for physical activities is also a major reason for generation of health disorders.

Rise in occurrence of diabetes and hypertension which are the most common diseases in United States raise the risk of getting affected of coronary heart disease. Strong economic position and well-developed healthcare infrastructure is aiding to the market growth of interventional cardiology devices. Rise in health awareness among the people is supporting the adoption of advanced medical treatment devices such as interventional cardiology devices which is accelerating the market growth. Increasing expenditure capacity among the patients and the high demand for quality treatment is paving the way for the interventional cardiology devices market growth.

United States interventional cardiology devices market is segmented into type, end user, regional distribution, and company. Based on end user, market can be further divided into hospitals & clinics, ambulatory surgery centers, and others. The hospitals & clinics segment is expected to account for major market share for the forecast period, 2023-2027.Favorable reimbursement policies and increasing prevalence of diabetes is the driving factor encouraging the patients to visit the healthcare facilities. Presence of all labs and healthcare professionals at a single place is another factor boosting the hospitals & clinics segment growth.

The major players operating in the United States interventional cardiology devices market are Medtronic USA, Inc., Boston Scientific Corporation, Abbott Laboratories, Inc., Biotronik, Inc., Edwards LifeSciences Corporation, Cardinal Health, Inc., B. Braun Medical Inc., Terumo Americas Holding Inc., Cordis Corporation, Cook Medical Inc., among others. Major companies are developing advanced technologies and launching new services to stay competitive in the market. Other competitive strategies include mergers & acquisitions and new service developments.

Objective of the Study:

  • To analyze the historical growth of the market size of United States interventional cardiology devices market from 2017 to 2020.
  • To estimate and forecast the market size of United States interventional cardiology devices market from 2021 to 2027 and growth rate until 2027.
  • To classify and forecast United States interventional cardiology devices market based on type, end user, regional distribution, and company.
  • To identify dominant region or segment in the United States interventional cardiology devices.
  • To identify drivers and challenges for United States interventional cardiology devices market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in United States interventional cardiology devices market.
  • To identify and analyze the profile of leading players operating in United States interventional cardiology devices market.
  • To identify key sustainable strategies adopted by market players in United States interventional cardiology devices market.


Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers who could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of United States interventional cardiology devices market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Interventional cardiology devices manufacturing companies
  • Market research and consulting firms
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums, and alliances related to interventional cardiology devices market.

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Attribute

Details

Base Year

2021

Historical Years

2017 – 2020

Estimated Year

2022E

Forecast Period

2023F – 2027F

Quantitative Units

Revenue in USD Million and CAGR for 2017-2021 and 2022E-2027F

Report Coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered

  • Type
  • End User

Region Scope

South-Region, West-Region, Mid-West Region & Northeast-Region

Key Companies Profiled

Medtronic USA, Inc., Boston Scientific Corporation, Abbott Laboratories, Inc., Biotronik, Inc., Edwards LifeSciences Corporation, Cardinal Health, Inc., B. Braun Medical Inc., Terumo Americas Holding Inc., Cordis Corporation, Cook Medical Inc.

Customization Scope

10% free report customization with purchase. Addition or alteration to regional & segment scope.

Pricing and Purchase Options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Report Scope:

In this report, United States interventional cardiology devices market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

·         United States Interventional Cardiology Devices Market, By Type:

    • Angioplasty Balloons
    • Angioplasty Stents
    • Structural Heart Devices
    • Catheters
    • Plaque Modification Devices
    • Hemodynamic Flow Alteration Devices
    • Others
  • United States Interventional Cardiology Devices Market, By End User:
    • Hospitals & Clinics
    • Ambulatory Surgery Centers
    • Others
  • United States Interventional Cardiology Devices Market, By Region:
    • South
    • West
    • Mid-West
    • North East

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in United States interventional cardiology devices market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
United States interventional cardiology devices market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on United States Interventional Cardiology Devices Market

4.    Voice of Customer

5.    Executive Summary

6.    United States Interventional Cardiology Devices Market Outlook

6.1.  Market Size & Forecast

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Product Type (Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Others)

6.2.2.     By End User (Hospitals & Clinics, Ambulatory Surgery Centers, Others)

6.2.3.     By Company (2021)

6.2.4.     By Region

6.3.  Product Market Map

7.    United States Angioplasty Balloons Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Type (Old/Normal Balloons, Drug-eluting Balloons, Cutting and Scoring Balloons)

7.2.2.     By End User

8.    United States Angioplasty Stents Devices Market Outlook

8.1.  Market Size & Forecast          

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Type (Drug-eluting Stents, Bare-metal Stents, Bioabsorbable Stents)

8.2.2.     By End User

9.    United States Structural Heart Devices Market Outlook

9.1.  Market Size & Forecast          

9.1.1.     By Value

9.2.  Market Share & Forecast

9.2.1.     By Type (Aortic Valve Therapy Devices, Mitral Valve, Pulmonary Valve, Others)

9.2.2.     By End User

10.  United States Interventional Cardiology Catheters Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value

10.2.              Market Share & Forecast

10.2.1.  By Type (Angiography Catheters, Guiding Catheters, IVUS/OCT Catheters)

10.2.2.  By End User

11.  United States Plaque Modification Devices Market Outlook

11.1.              Market Size & Forecast

11.1.1.  By Value

11.2.              Market Share & Forecast

11.2.1.  By Type (Atherectomy Devices v/s Thrombectomy Devices)

11.2.2.  By End User

12.  United States Hemodynamic Flow Alteration Devices Market Outlook

12.1.              Market Size & Forecast

12.1.1.  By Value

12.2.              Market Share & Forecast

12.2.1.  By Type (Embolic Protection Devices v/s Chronic Total Occlusion Devices)

12.2.2.  By End User

13.  Market Dynamics

13.1.              Drivers

13.2.              Challenges

14.  Market Trends & Developments

15.  Policy & Regulatory Landscape

16.  United States Economic Profile

17.  Competitive Landscape

17.1.              Medtronic USA, Inc.

17.2.              Boston Scientific Corporation

17.3.              Abbott Laboratories, Inc.

17.4.              Biotronik, Inc.

17.5.              Edwards LifeSciences Corporation

17.6.              Cardinal Health, Inc.

17.7.              B. Braun Medical Inc.

17.8.              Terumo Americas Holding Inc.

17.9.              Cordis Corporation

17.10.            Cook Medical Inc.

18.  Strategic Recommendations

Figures and Tables

Frequently asked questions

down-arrow

Increasing cases of cardiovascular diseases, higher healthcare expenditure and rising disposable income among the country population are driving the growth of the United States interventional cardiology devices market in the forecast years, 2023-2027.

down-arrow

Medtronic USA, Inc., Boston Scientific Corporation, Abbott Laboratories, Inc., Biotronik, Inc., Edwards LifeSciences Corporation, among others are some of the leading companies dedicated toward providing related products and services and support the future growth of the United States interventional cardiology devices market in the upcoming five years.

down-arrow

New market players may invest actively in research and innovative product development. Also, advancing their existent technology according to evolving consumer preferences along with merger and acquisitions with the global giants can be viable strategic recommendations for the future brand establishments.

down-arrow

The United States interventional cardiology devices market analysis was analyzed for the five historical years from 2017 to 2020. Keeping the base year 2020 as the margin, the estimation for the year 2022 was made and further market growth is predicted for the forecast years, 2023 to 2027.

profile

Sakshi Bajaal

Business Consultant
Press Release

Bio-Succinic Acid Market to Grow with a CAGR of 4.43% through 2029

May, 2024

Stringent Regulations on Petrochemical based Products are expected to drive the Global Bio-Succinic Acid Market growth in the forecast period, 2025-2029.